Bill > HB2144

This bill requires manufacturers, wholesale distributors, and medical equipment suppliers licensed or registered with the Board of Pharmacy to submit an annual report detailing their direct-to-consumer advertising expenditures for prescription drugs and medical devices. Specifically, these entities must file a report by January 30th of each year, covering the spending from the previous calendar year, using forms provided by the Board of Pharmacy. The report must break down the amount spent on advertising for each individual prescription drug or device. The Board of Pharmacy is then required to compile these reports and publish a comprehensive summary of the advertising spending by May 1st of the same year. This bill aims to increase transparency around pharmaceutical and medical device advertising expenditures by creating a mandatory reporting mechanism that allows the public and regulators to track how much money is being spent on direct-to-consumer advertising in the healthcare industry.

Business and Industry

https://lis.virginia.gov/bill-details/20251/HB2144